Literature DB >> 6274912

Apolipoprotein C-III-1 activates lysosomal sphingomyelinase in vitro.

A J Alpert, A L Beaudet.   

Abstract

Apolipoprotein (apo)C-III-1 from human very low density lipoprotein stimulates 14-fold the activity of lysosomal sphingomyelinase from human fibroblasts. At the sphingomyelin concentrations tested, maximal stimulation was obtained with 5 microM apoC-III-1 or apoC mixture. Apolipoproteins A-I, A-II, B, and C-I conferred little or no stimulation. Sphingomyelinase was stimulated 20-fold by lysophosphatidylcholine with an optimum concentration of 70 microM using 0.3 mM substrate. Sphingomyelinase activity was inhibited by concentrations of apoC-III-1 and lysophosphatidylcholine three- to fivefold above stimulatory levels. Triton X-100 activated sphingomyelinase 300-fold with a pH optimum of 5.0, while the pH optimum with the biological activators was 4.0. These results raise the possibility of an in vivo activity for the biological activators. The proteins that enter lysosomes as part of a lipoprotein complex may activate lysosomal enzymes that degrade the lipid components.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6274912      PMCID: PMC370964          DOI: 10.1172/jci110414

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  27 in total

1.  Glucocerebrosidase: stoichiometry of association between effector and catalytic proteins.

Authors:  M W HO; M Rigby
Journal:  Biochim Biophys Acta       Date:  1975-07-27

2.  Magnesium-dependent sphingomyelinase.

Authors:  S Gatt
Journal:  Biochem Biophys Res Commun       Date:  1976-01-12       Impact factor: 3.575

3.  Effect of the human plasma apolipoproteins and phosphatidylcholine acyl donor on the activity of lecithin: cholesterol acyltransferase.

Authors:  A K Soutar; C W Garner; H N Baker; J T Sparrow; R L Jackson; A M Gotto; L C Smith
Journal:  Biochemistry       Date:  1975-07-15       Impact factor: 3.162

4.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

5.  Receptor-dependent hydrolysis of cholesteryl esters contained in plasma low density lipoprotein.

Authors:  M S Brown; S E Dana; J L Goldstein
Journal:  Proc Natl Acad Sci U S A       Date:  1975-08       Impact factor: 11.205

6.  Further observations on the activation and inhibition of lipoprotein lipase by apolipoproteins.

Authors:  R M Krauss; P N Herbert; R I Levy; D S Fredrickson
Journal:  Circ Res       Date:  1973-10       Impact factor: 17.367

7.  Acid lipase in cultured fibroblasts: cholesterol ester storage disease.

Authors:  A L Beaudet; M H Lipson; G D Ferry; B L Nichols
Journal:  J Lab Clin Med       Date:  1974-07

8.  Studies of the proteins in human plasma very low density lipoproteins.

Authors:  W V Brown; R I Levy; D S Fredrickson
Journal:  J Biol Chem       Date:  1969-10-25       Impact factor: 5.157

9.  Effects of apolipoproteins on lipoprotein lipase activity of human adipose tissue.

Authors:  R Ekman; P Nilsson-Ehle
Journal:  Clin Chim Acta       Date:  1975-08-18       Impact factor: 3.786

10.  The metabolism of sphingomyelin. I. Purification and properties of a sphingomyelin-cleaving enzyme from rat liver tissue.

Authors:  J N Kanfer; O M Young; D Shapiro; R O Brady
Journal:  J Biol Chem       Date:  1966-03-10       Impact factor: 5.157

View more
  2 in total

1.  Analysis of the multiple forms of Gaucher spleen sphingolipid activator protein 2.

Authors:  B C Paton; A Poulos
Journal:  Biochem J       Date:  1988-08-15       Impact factor: 3.857

2.  Concentrations of an activator protein for sphingolipid hydrolysis in liver and brain samples from patients with lysosomal storage diseases.

Authors:  K Inui; D A Wenger
Journal:  J Clin Invest       Date:  1983-11       Impact factor: 14.808

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.